keyword
https://read.qxmd.com/read/38630478/immune-checkpoint-inhibitor-use-during-pregnancy-and-outcomes-in-pregnant-individuals-and-newborns
#1
JOURNAL ARTICLE
Paul Gougis, Anne-Sophie Hamy, Floriane Jochum, Kevin Bihan, Marie Carbonnel, Joe-Elie Salem, Elise Dumas, Rayan Kabirian, Beatriz Grandal, Solenn Barraud, Florence Coussy, Judicael Hotton, Raphaelle Savarino, Aurélien Marabelle, Jacques Cadranel, Jean-Philippe Spano, Enora Laas, Fabien Reyal, Baptiste Abbar
IMPORTANCE: With the widespread use of immune checkpoint inhibitors (ICIs), concerns about their pregnancy outcomes through maternal exposure have emerged, and clinical comparative data are lacking. OBJECTIVE: To assess the risk of pregnancy-, fetal-, and/or newborn-related adverse outcomes associated with exposure to ICIs compared with exposure to other anticancer agents. DESIGN, SETTING, AND PARTICIPANTS: In this cohort study, all reports mentioning a pregnancy-related condition and an antineoplastic agent (Anatomical Therapeutic Chemical classification group L01) used for a cancer indication registered in the World Health Organization international pharmacovigilance database VigiBase up to June 26, 2022, were extracted...
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38607625/incidence-and-presenting-characteristics-of-angiosarcoma-in-the-us-2001-2020
#2
JOURNAL ARTICLE
Michael J Wagner, Vinod Ravi, Stephanie K Schaub, Ed Y Kim, Jeremy Sharib, Harveshp Mogal, Min Park, Michaela Tsai, Daniela Duarte-Bateman, Anthony Tufaro, Elizabeth T Loggers, Lee D Cranmer, Bonny Chau, Michael J Hassett, Juneko Grilley-Olson, Kelly G Paulson
IMPORTANCE: Angiosarcoma is an aggressive vascular malignant neoplasm presenting either as a primary or secondary cancer, often arising after radiotherapy or in the context of preexisting lymphedema. Comprehensive data describing its incidence and presentation patterns are needed. OBJECTIVE: To describe the incidence, presenting characteristics, and change over time of angiosarcoma in the US. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cross-sectional study used data from the US Cancer Statistics (USCS) National Program of Cancer Registries-Surveillance, Epidemiology, and End Results Combined Database, which captures more than 99% of newly diagnosed cancers in the US...
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38546604/genetic-associations-of-primary-angle-closure-disease-a-systematic-review-and-meta-analysis
#3
JOURNAL ARTICLE
Yu Jing Liang, Yu Yao Wang, Shi Song Rong, Zhen Ji Chen, Shu Ying Chen, Jenson A Tham, Poemen P Chan, Jason C Yam, Janey L Wiggs, Chi Pui Pang, Clement C Tham, Li Jia Chen
IMPORTANCE: Effects of genetic variants on primary angle-closure disease remained uncertain. OBJECTIVE: To systematically review the associations of common single-nucleotide variants (SNVs) and rare coding variants with primary angle-closure disease, its subtypes (including primary angle-closure glaucoma, primary angle-closure suspect, and primary angle-closure) and progression. DATA SOURCES: Eligible studies from PubMed, Embase, and Web of Science were retrieved up to April 3, 2023...
March 28, 2024: JAMA Ophthalmology
https://read.qxmd.com/read/38536168/persistent-cutaneous-lesions-of-darier-disease-and-second-hit-somatic-variants-in-atp2a2-gene
#4
JOURNAL ARTICLE
Lihi Atzmony, Fadia Zagairy, Banan Mawassi, Majd Shehade, Yasmin Tatour, Nada Danial-Farran, Morad Khayat, Nassim Warrour, Roni Dodiuk-Gad, Eran Cohen-Barak
IMPORTANCE: Darier disease (DD) is a rare genetic skin disorder caused by heterozygous variants in the ATP2A2 gene. Clinical manifestations include recurrent hyperkeratotic papules and plaques that occur mainly in seborrheic areas. Although some of the lesions wax and wane in response to environmental factors, others are severe and respond poorly to therapy. OBJECTIVE: To investigate the molecular mechanism underlying the persistency of skin lesions in DD. DESIGN, SETTING, AND PARTICIPANTS: In this case series, DNA was extracted from unaffected skin, transient and persistent lesional skin, and blood from 9 patients with DD...
March 27, 2024: JAMA Dermatology
https://read.qxmd.com/read/38497971/magnetic-resonance-imaging-characteristics-of-lgi1-antibody-and-caspr2-antibody-encephalitis
#5
JOURNAL ARTICLE
Mark J Kelly, Eleanor Grant, Andrew G Murchison, Sophie Binks, Sudarshini Ramanathan, Sophia Michael, Adam E Handel, Lahiru Handunnetthi, Christopher E Uy, John N Soltys, Divyanshu Dubey, Gregory S Day, A Sebastian Lopez-Chiriboga, Eoin P Flanagan, Fintan Sheerin, Sarosh R Irani
IMPORTANCE: Rapid and accurate diagnosis of autoimmune encephalitis encourages prompt initiation of immunotherapy toward improved patient outcomes. However, clinical features alone may not sufficiently narrow the differential diagnosis, and awaiting autoantibody results can delay immunotherapy. OBJECTIVE: To identify simple magnetic resonance imaging (MRI) characteristics that accurately distinguish 2 common forms of autoimmune encephalitis, LGI1- and CASPR2-antibody encephalitis (LGI1/CASPR2-Ab-E), from 2 major differential diagnoses, viral encephalitis (VE) and Creutzfeldt-Jakob disease (CJD)...
March 18, 2024: JAMA Neurology
https://read.qxmd.com/read/38477886/prevalence-and-patient-characteristics-of-ectodermal-dysplasias-in-denmark
#6
JOURNAL ARTICLE
Laura Krogh Herlin, Sigrun A J Schmidt, Xenia Buus Hermann, Kirsten Rønholt, Anette Bygum, Annette Schuster, Ulrikke Lei, Mette Mogensen, Gabrielle R Vinding, Malene Djursby, Hanne Hove, Jenny Blechingberg, Lise Graversen, Trine H Mogensen, Hans Gjørup, Sinéad M Langan, Mette Sommerlund
IMPORTANCE: Ectodermal dysplasias constitute a group of rare genetic disorders of the skin and skin appendages with hypodontia, hypotrichosis, and hypohidrosis as cardinal features. There is a lack of population-based research into the epidemiology of ectodermal dysplasias. OBJECTIVE: To establish a validated population-based cohort of patients with ectodermal dysplasia in Denmark and to assess the disease prevalence and patient characteristics. DESIGN, SETTING, AND PARTICIPANTS: This nationwide cohort study used individual-level registry data recorded across the Danish universal health care system to identify patients with ectodermal dysplasias from January 1, 1995, to August 25, 2021...
March 13, 2024: JAMA Dermatology
https://read.qxmd.com/read/38451503/a-rare-case-of-sudden-massive-neck-tumor
#7
JOURNAL ARTICLE
Jianyong Zhang, Xin Zhu
No abstract text is available yet for this article.
April 1, 2024: JAMA Otolaryngology—Head & Neck Surgery
https://read.qxmd.com/read/38446447/anatomic-subtype-differences-in-extramammary-paget-disease-a-meta-analysis
#8
JOURNAL ARTICLE
Nour Kibbi, Joshua L Owen, Brandon Worley, Jake X Wang, Vishnu Harikumar, Sumaira Z Aasi, Sunandana Chandra, Jennifer N Choi, Yasuhiro Fujisawa, Christos Iavazzo, John Y S Kim, Naomi Lawrence, Mario M Leitao, Allan B MacLean, Jeffrey S Ross, Anthony M Rossi, Sabah Servaes, Michael J Solomon, Murad Alam
IMPORTANCE: Extramammary Paget disease (EMPD) is a rare, highly recurrent cutaneous malignant neoplasm of unclear origin. EMPD arises most commonly on the vulvar and penoscrotal skin. It is not presently known how anatomic subtype of EMPD affects disease presentation and management. OBJECTIVE: To compare demographic and tumor characteristics and treatment approaches for different EMPD subtypes. Recommendations for diagnosis and treatment are presented. DATA SOURCES: MEDLINE, Embase, Web of Science Core Collection, and Cochrane Reviews CENTRAL from December 1, 1990, to October 24, 2022...
March 6, 2024: JAMA Dermatology
https://read.qxmd.com/read/38416489/hourly-heat-exposure-and-acute-ischemic-stroke
#9
JOURNAL ARTICLE
Xinlei Zhu, Renjie Chen, Jing Yuan, Yang Liu, Yong Wang, Xunming Ji, Haidong Kan, Jing Zhao
IMPORTANCE: Previous studies have demonstrated the associations of daily high temperature with hospitalizations and mortality from ischemic stroke, but the hourly association of ambient heat and acute ischemic stroke (AIS) onset has been rarely examined. OBJECTIVES: To evaluate the association between hourly high ambient temperature and the onset of AIS. DESIGN, SETTING, AND PARTICIPANTS: This time-stratified case-crossover study was conducted using a nationwide registry that collects data from more than 200 stroke centers in China...
February 5, 2024: JAMA Network Open
https://read.qxmd.com/read/38363571/covid-19-in-pediatric-patients-with-acute-lymphoblastic-leukemia-or-lymphoma
#10
JOURNAL ARTICLE
Saman K Hashmi, Jessica Bodea, Tushar Patni, Savannah Angel, Nickhill H Bhakta, Sima Jeha, Seth E Karol, Raul C Ribeiro, Jeffrey E Rubnitz, Joshua Wolf, Yimei Li, Ching-Hon Pui, Diego R Hijano, Hiroto Inaba
IMPORTANCE: COVID-19 in pediatric patients with acute lymphoblastic leukemia or lymphoma (ALL/LLy) has not been described in detail and may affect chemotherapy administration and long-term outcomes. OBJECTIVE: To describe the clinical presentation of COVID-19 and chemotherapy modifications in pediatric patients with ALL/LLy. DESIGN, SETTING, AND PARTICIPANTS: This is a retrospective case series of patients at St Jude Children's Research Hospital and its affiliate sites with newly diagnosed ALL/LLy who were treated on the Total XVII protocol (NCT03117751) between March 30, 2020, and June 20, 2022...
February 5, 2024: JAMA Network Open
https://read.qxmd.com/read/38348206/extensive-phenotypic-variability-in-syndrome-dysmorphic-facies-renal-agenesis-ambiguous-genitalia-microcephaly-polydactyly-and-lissencephaly-dream-pl-a-case-report-highlighting-diagnostic-and-management-challenges
#11
Amin I Shaaban, Fikry M Lotfy, Mussaed S Alharbi, Ahmed F Zaky, Rand R Al Sari, Rakan K Mattar, Hussain A Al Mubarak, Amaal Jama, Shahad M Mousa, Nagham A Borah, Fatimah M Alshami, Futoon F Afandy, Sahar H Fadda
The dysmorphic facies, renal agenesis, ambiguous genitalia, microcephaly, polydactyly, and lissencephaly (DREAM-PL) syndrome is a rare autosomal recessive disorder characterized by dysmorphic facies, renal agenesis, ambiguous genitalia in males, microcephaly, polydactyly, and lissencephaly. The CTU2 gene, which encodes a protein involved in the post-transcriptional modification of tRNAs is the source of the syndrome's mutation. Several developmental abnormalities can result from a disruption of this modification, which is necessary for the proper translation of genes...
February 2024: Curēus
https://read.qxmd.com/read/38294784/estimated-spending-on-beremagene-geperpavec-for-dystrophic-epidermolysis-bullosa
#12
JOURNAL ARTICLE
Adam J N Raymakers, Aaron S Kesselheim, Arash Mostaghimi, William B Feldman
IMPORTANCE: New gene therapies can offer substantial benefits to patients, particularly those with rare diseases who have few therapeutic options. In May 2023, the US Food and Drug Administration (FDA) approved the first topical gene therapy, beremagene geperpavec (B-VEC), for treating both autosomal recessive and autosomal dominant dystrophic epidermolysis bullosa (DEB). However, FDA approval was based on limited data in patients with autosomal dominant disease, even though they comprise approximately 50% of all DEB cases...
January 31, 2024: JAMA Dermatology
https://read.qxmd.com/read/38277989/treatment-recommendations-for-glycogen-storage-disease-type-ib-associated-neutropenia-and-neutrophil-dysfunction-with-empagliflozin-consensus-from-an-international-workshop
#13
REVIEW
Sarah C Grünert, Terry G J Derks, Helen Mundy, R Neil Dalton, Jean Donadieu, Peter Hofbauer, Neil Jones, Sema Kalkan Uçar, Jamas LaFreniere, Enrique Landelino Contreras, Surekha Pendyal, Alessandro Rossi, Blair Schneider, Ronen Spiegel, Karolina M Stepien, Dorota Wesol-Kucharska, Maria Veiga-da-Cunha, Saskia B Wortmann
Glycogen storage disease type Ib (GSD Ib, biallelic variants in SLC37A4) is a rare disorder of glycogen metabolism complicated by neutropenia/neutrophil dysfunction. Since 2019, the SGLT2-inhibitor empagliflozin has provided a mechanism-based treatment option for the symptoms caused by neutropenia/neutrophil dysfunction (e.g. mucosal lesions, inflammatory bowel disease). Because of the rarity of GSD Ib, the published evidence on safety and efficacy of empagliflozin is still limited and does not allow to develop evidence-based guidelines...
January 17, 2024: Molecular Genetics and Metabolism
https://read.qxmd.com/read/38265806/polygenic-risk-in-families-with-spontaneous-coronary-artery-dissection
#14
JOURNAL ARTICLE
Ingrid Tarr, Stephanie Hesselson, Michael Troup, Paul Young, Jamie-Lee Thompson, Lucy McGrath-Cadell, Diane Fatkin, Sally L Dunwoodie, David W M Muller, Siiri E Iismaa, Jason C Kovacic, Robert M Graham, Eleni Giannoulatou
IMPORTANCE: Spontaneous coronary artery dissection (SCAD) is a poorly understood cause of acute coronary syndrome that predominantly affects women. Evidence to date suggests a complex genetic architecture, while a family history is reported for a minority of cases. OBJECTIVE: To determine the contribution of rare and common genetic variants to SCAD risk in familial cases, the latter via the comparison of a polygenic risk score (PRS) with those with sporadic SCAD and healthy controls...
January 24, 2024: JAMA Cardiology
https://read.qxmd.com/read/38265770/retrospective-case-series-of-cocaine-associated-plasma-cell-orificial-mucositis
#15
JOURNAL ARTICLE
Myriam Viedma-Martinez, Gonzalo Gallo-Pineda, Miguel Recio-Monescillo, David Jimenez-Gallo, Pablo Lopez-Sanz, Marta Drake-Monfort, Peru Urigoitia-Ugalde, Vicenta Martínez-Signes, David Llorca-Juan, Laura Fuertes-Vega, Elisa Ríos-Viñuela, Eduardo Escario-Travesedo, Juan José Ríos-Martín, Luis Requena-Caballero, Mario Linares-Barrios
IMPORTANCE: Plasma cell orificial mucositis (PCOM) associated with cocaine use is an emerging, rare condition that has become a concern in Spain in recent years. Limited knowledge exists regarding this novel condition. OBJECTIVES: To delineate the clinicopathologic characteristics of this emerging entity and establish a novel approach in the differential diagnosis of cocaine-associated lesions. DESIGN, SETTING, AND PARTICIPANTS: A descriptive, retrospective, multicenter case series of 10 patients diagnosed with cocaine-associated PCOM was conducted in Spain from April 2020 to March 2023...
January 24, 2024: JAMA Dermatology
https://read.qxmd.com/read/38227312/nighttime-outdoor-artificial-light-and-risk-of-age-related-macular-degeneration
#16
JOURNAL ARTICLE
Su Hwan Kim, Young Kook Kim, Young In Shin, Goneui Kang, Seong Pyo Kim, Hajoung Lee, In Hwan Hong, In Boem Chang, Soon-Beom Hong, Hyung-Jin Yoon, Ahnul Ha
IMPORTANCE: Light pollution's impact on human health is increasingly recognized, but its link to exudative age-related macular degeneration (EAMD) remains unclear. OBJECTIVE: To investigate the association between exposure to outdoor artificial light at night (OALAN) and the risk of incident EAMD. DESIGN, SETTING, AND PARTICIPANTS: In this nationwide population-based case-control study, all individuals 50 years or older with newly diagnosed EAMD between January 1, 2010, and December 31, 2011, were identified with reference to the Korean National Health Insurance Service registration program database for rare and intractable diseases...
January 2, 2024: JAMA Network Open
https://read.qxmd.com/read/38170500/genetic-risk-factors-for-early-onset-merkel-cell-carcinoma
#17
JOURNAL ARTICLE
Noreen Mohsin, Devin Hunt, Jia Yan, Austin J Jabbour, Paul Nghiem, Jaehyuk Choi, Yue Zhang, Alexandra F Freeman, Jenna R E Bergerson, Stefania Dell'Orso, Kristina Lachance, Rima Kulikauskas, Loren Collado, Wenjia Cao, Justin Lack, Morgan Similuk, Bryce A Seifert, Rajarshi Ghosh, Magdalena A Walkiewicz, Isaac Brownell
IMPORTANCE: Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine skin cancer. Of the patients who develop MCC annually, only 4% are younger than 50 years. OBJECTIVE: To identify genetic risk factors for early-onset MCC via genomic sequencing. DESIGN, SETTING, AND PARTICIPANTS: The study represents a multicenter collaboration between the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Institute of Allergy and Infectious Diseases (NIAID), and the University of Washington...
January 3, 2024: JAMA Dermatology
https://read.qxmd.com/read/38153731/self-reported-frequency-of-adding-salt-to-food-and-risk-of-incident-chronic-kidney-disease
#18
JOURNAL ARTICLE
Rui Tang, Minghao Kou, Xuan Wang, Hao Ma, Xiang Li, Yoriko Heianza, Lu Qi
IMPORTANCE: The self-reported frequency of adding salt to foods could reflect a person's long-term salt taste preference, and salt intake has been associated with increased risk of cardiovascular diseases (CVD). Whether self-reported adding of salt to foods is associated with increased risk of chronic kidney disease (CKD) remains unknown. OBJECTIVE: To prospectively examine the association of self-reported frequency of adding salt to foods with incident CKD risk in a general population of adults...
December 1, 2023: JAMA Network Open
https://read.qxmd.com/read/38100106/biomarker-testing-in-patients-with-unresectable-advanced-or-recurrent-non-small-cell-lung-cancer
#19
JOURNAL ARTICLE
Tomohiro Sakamoto, Taichi Matsubara, Takayuki Takahama, Toshihide Yokoyama, Atsushi Nakamura, Takaaki Tokito, Tatsuro Okamoto, Hiroaki Akamatsu, Masahide Oki, Yuki Sato, Kazunori Tobino, Satoshi Ikeda, Masahide Mori, Chihiro Mimura, Ken Maeno, Satoru Miura, Toshiyuki Harada, Kunihiro Nishimura, Manabu Hiraoka, Hirotsugu Kenmotsu, Junya Fujimoto, Mototsugu Shimokawa, Nobuyuki Yamamoto, Kazuhiko Nakagawa
IMPORTANCE: Biomarker testing for driver mutations is essential for selecting appropriate non-small cell lung cancer (NSCLC) treatment but is insufficient. OBJECTIVE: To investigate the status of biomarker testing and drug therapy for NSCLC in Japan for identifying problems in treatment. DESIGN, SETTING, AND PARTICIPANTS: The REVEAL cohort study included retrospective data collection and prospective follow-up from 29 institutions across Japan...
December 1, 2023: JAMA Network Open
https://read.qxmd.com/read/38003995/tolerated-re-challenge-of-immunotherapy-in-a-patient-with-ici-associated-myocarditis-a-case-report-and-literature-review
#20
REVIEW
Walid Shalata, Zoé Gabrielle Attal, Rajeh Shhadi, Amjad Abu Salman, Ashraf Abu Jama, Sondos Shalata, Kais Halumi, Alexander Yakobson
Many different types of cancer can be treated with immunotherapy drugs called immune checkpoint inhibitors (ICIs). These drugs have altered the landscape of cancer treatment options since they function by triggering a stronger immune response to malignancy. As expected, ICIs' modification of immune regulatory controls leads to a wide range of organ/gland-specific immune-related side effects. These adverse effects are uncommonly deadly and typically improve by discontinuing treatment or administering corticosteroid drugs...
November 3, 2023: Medicina
keyword
keyword
158136
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.